OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.

OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.

OX40, a member of the tumor necrosis factor (TNF) receptor/nerve growth factor (NGF) receptor superfamily was first identified as a marker of activated rat CD4+ cells with the MRC OX40 monoclonal antibody (mAb). A ligand for OX40 (called OX40 ligand or OX40L) has recently been identified and has seq...

Bibliografski detalji
Glavni autori:	al-Shamkhani, A, Birkeland, M, Puklavec, M, Brown, M, James, W, Barclay, A
Format:	Journal article
Jezik:	English
Izdano:	1996

Slični predmeti

Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells.
od: Al-Shamkhani, A, i dr.
Izdano: (1997)

Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
od: Ayaka Sato, i dr.
Izdano: (2025-01-01)

Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia
od: Dawei Cui, i dr.
Izdano: (2019-01-01)

Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis
od: Xiaoling Zhou, i dr.
Izdano: (2022-01-01)

An OX-Tra’Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis
od: Kaviyon Sadrolashrafi, i dr.
Izdano: (2024-03-01)

Role of OX40-OX40L interactions in the immune response to solid organ allografts
od: Kinnear, G
Izdano: (2013)

OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis—Focus on Rocatinlimab and Amlitelimab
od: Ana Maria Lé, i dr.
Izdano: (2022-12-01)

Mast Cell-Derived Exosomes Promote Th2 Cell Differentiation via OX40L-OX40 Ligation
od: Fei Li, i dr.
Izdano: (2016-01-01)

699 A differentiated anti-OX40 agonist BGB-A445 does not block OX40-OX40L interaction and reveals remarkable anti-tumor efficacy in preclinical models
od: Bo Zhang, i dr.
Izdano: (2020-11-01)

Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy
od: Aliya I Sani, i dr.
Izdano: (2021-07-01)

Non-viral-mediated gene transfer of OX40 ligand for tumor immunotherapy
od: Olga A. Rakitina, i dr.
Izdano: (2024-06-01)

Research progress on OX40/OX40L axis mediated T cell immunity in the course of oral lichen planus
od: LIU Yang, i dr.
Izdano: (2022-07-01)

Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma
od: Xianlong Chen, i dr.
Izdano: (2022-07-01)

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
od: Peixin Chen, i dr.
Izdano: (2021-11-01)

OX40L/OX40 Signal Promotes IL-9 Production by Mucosal MAIT Cells During Helicobacter pylori Infection
od: Siqi Ming, i dr.
Izdano: (2021-03-01)

OX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice.
od: Jinchuan Yan, i dr.
Izdano: (2013-01-01)

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
od: Erkko Ylösmäki, i dr.
Izdano: (2021-03-01)

Development of OX40 agonists for canine cancer immunotherapy
od: Damien Ruiz, i dr.
Izdano: (2022-10-01)

OX40 is required for regulatory T cell-mediated control of colitis.
od: Griseri, T, i dr.
Izdano: (2010)

A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab
od: Asaad Abdelhalim, i dr.
Izdano: (2024-11-01)

Relationship between bladder cancer and polymorphisms of OX40 (rs17568) and OX40L (rs1234313) genes in a Turkish population
od: Osman Bilen, i dr.
Izdano: (2023-03-01)

Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D)
od: Jingnan An, i dr.
Izdano: (2019-01-01)

Domain binding and isotype dictate the activity of anti-human OX40 antibodies
od: C Ian Mockridge, i dr.
Izdano: (2020-10-01)

Activation of OX40 and CD27 Costimulatory Signalling in Sheep through Recombinant Ovine Ligands
od: José Manuel Rojas, i dr.
Izdano: (2020-06-01)

Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function.
od: Wright, G, i dr.
Izdano: (2000)

Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor.
od: Mallett, S, i dr.
Izdano: (1990)

Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.
od: William L Redmond, i dr.
Izdano: (2012-01-01)

The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans
od: Wright, G, i dr.
Izdano: (2001)

The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans.
od: Wright, G, i dr.
Izdano: (2001)

Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism
od: Q. Dong, i dr.
Izdano: (2013-09-01)

Anti-OX40Ligand treatment as a novel therapeutic strategy in a murine model of colitis
od: Singh, B, i dr.
Izdano: (2001)

OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia
od: Taizou Hirano, i dr.
Izdano: (2016-03-01)

OX40 facilitates control of a persistent virus infection.
od: Tobias Boettler, i dr.
Izdano: (2012-09-01)

Breaking Immunological Tolerance through OX40 (CD134)
od: Pratima Bansal-Pakala, i dr.
Izdano: (2001-01-01)

OX40 agonists and combination immunotherapy: putting the pedal to the metal
od: Stefanie N Linch, i dr.
Izdano: (2015-02-01)

Tissue specific deletion of inhibitor of kappa B kinase 2 with OX40-Cre reveals the unanticipated expression from the OX40 locus in skin epidermis.
od: Georgina H Cornish, i dr.
Izdano: (2012-01-01)

OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis.
od: Gwyer Findlay, E, i dr.
Izdano: (2014)

Blockade of OX40-OX40L Interactions Attenuates Allograft Rejection Mediated by CD4 T Cells That Recognize Alloantigen through the Direct but Not Indirect Pathway of Allorecognition
od: Kinnear, G, i dr.
Izdano: (2012)

Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors
od: Daniele E. Mascarelli, i dr.
Izdano: (2021-06-01)

IL-33 Promotes the Induction and Maintenance of Th2 Immune Responses by Enhancing the Function of OX40 Ligand
od: Naoko Murakami-Satsutani, i dr.
Izdano: (2014-01-01)